← Leaderboards
Dana Pe'er
Columbia Univ New York Morningside
$22,897,615
Attributed
$23,977,242
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.9M · FY2007–25$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$36,838,937 · 11
By mechanism
U2C$23,608,961 · 4
DP1$4,163,360 · 1
R01$4,037,937 · 2
U54$2,523,719 · 3
DP2$2,504,960 · 1
Top collaborators
- Christine A Iacobuzio-Donahue5 shared
- Scott W Lowe3 shared
Most similar at Columbia Univ New York Morningside
Same institution · by research overlap
- Liang Tong$20,131,258
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorCellsMalignant NeoplasmsTechnologyAtlasesMolecularSamplingMapsNeoplasm MetastasisProgramsComplexMemorial Sloan-Kettering Cancer CenterMalignant Neoplasm Of PancreasGenomicsResolutionCell TypeData AnalysesBaseMetastatic Malignant Neoplasm To BrainMetastatic ToMalignant Neoplasm Of LungProteinsComputing MethodologiesInsight
Grant awards (44)
Mechanisms of p53 Engagement and Action at the Benign-to-Malignant Transition in Sporadic Tumorigenesis$734,550
R01 · FY2025 · CA
Shared Resource Core: Computational and technology development for spatial expression analysis.$442,500
U54 · FY2025 · CA · contact PI
Mechanisms of p53 Engagement and Action at the Benign-to-Malignant Transition in Sporadic Tumorigenesis$697,824
R01 · FY2024 · CA
Shared Resource Core: Computational and technology development for spatial expression analysis.$287,625
U54 · FY2024 · CA · contact PI
Mechanisms of p53 Engagement and Action at the Benign-to-Malignant Transition in Sporadic Tumorigenesis$726,881
R01 · FY2023 · CA
Shared Resource Core: Computational and technology development for spatial expression analysis.$300,900
U54 · FY2023 · CA · contact PI
Transition to Metastatic State: Lung Cancer, Pancreatic Cancer and Brain Metastasis$2,576,383
U2C · FY2022 · CA · contact PI
Molecular, Cellular, and Tissue Characterization Unit$1,099,561
U2C · FY2022 · CA · contact PI
Administrative Core$574,244
U2C · FY2022 · CA · contact PI
Data Processing, Analysis and Modeling Unit$550,875
U2C · FY2022 · CA · contact PI
Shared Resource Core: Computational and technology development for spatial expression analysis.$339,251
U54 · FY2022 · CA · contact PI
Transition to Metastatic State: Lung Cancer, Pancreatic Cancer and Brain Metastasis$2,111,318
U2C · FY2021 · CA · contact PI
Molecular, Cellular, and Tissue Characterization Unit$1,008,368
U2C · FY2021 · CA · contact PI
Administrative Core$449,892
U2C · FY2021 · CA · contact PI
Data Processing, Analysis and Modeling Unit$425,707
U2C · FY2021 · CA · contact PI
Transition to Metastatic State: Lung Cancer, Pancreatic Cancer and Brain Metastasis$2,665,572
U2C · FY2020 · CA · contact PI
Molecular, Cellular, and Tissue Characterization Unit$1,194,636
U2C · FY2020 · CA · contact PI
Administrative Core$579,072
U2C · FY2020 · CA · contact PI
Data Processing, Analysis and Modeling Unit$554,259
U2C · FY2020 · CA · contact PI
CORE 1: SHARED RESOURCE CORE$249,313
U54 · FY2020 · CA · contact PI
Transition to Metastatic State: Lung Cancer, Pancreatic Cancer and Brain Metastasis$2,801,826
U2C · FY2019 · CA · contact PI
Molecular, Cellular, and Tissue Characterization Unit$1,137,550
U2C · FY2019 · CA · contact PI
Administrative Core$579,072
U2C · FY2019 · CA · contact PI
Data Processing, Analysis and Modeling Unit$553,655
U2C · FY2019 · CA · contact PI
CORE 1: SHARED RESOURCE CORE$232,624
U54 · FY2019 · CA · contact PI
Transition to Metastatic State: Lung Cancer, Pancreatic Cancer and Brain Metastasis$2,706,596
U2C · FY2018 · CA · contact PI
Molecular, Cellular, and Tissue Characterization Unit$1,014,589
U2C · FY2018 · CA · contact PI
Single cell mapping of developmental trajectories underlying health and disease$864,000
DP1 · FY2018 · HD · contact PI
Administrative Core$579,072
U2C · FY2018 · CA · contact PI
Data Processing, Analysis and Modeling Unit$446,714
U2C · FY2018 · CA · contact PI
CORE 1: SHARED RESOURCE CORE$245,301
U54 · FY2018 · CA · contact PI
Single cell mapping of developmental trajectories underlying health and disease$864,000
DP1 · FY2017 · HD · contact PI
CORE 1: SHARED RESOURCE CORE$213,725
U54 · FY2017 · CA · contact PI
Single cell mapping of developmental trajectories underlying health and disease$855,360
DP1 · FY2016 · HD · contact PI
Integrative Cancer Genomics: Drivers, Pathways and Drugs$464,984
R01 · FY2016 · CA · contact PI
CORE 1: SHARED RESOURCE CORE$212,480
U54 · FY2016 · CA · contact PI
Single cell mapping of developmental trajectories underlying health and disease$780,000
DP1 · FY2015 · HD · contact PI
Integrative Cancer Genomics: Drivers, Pathways and Drugs$554,295
R01 · FY2015 · CA · contact PI
Single cell mapping of developmental trajectories underlying health and disease$800,000
DP1 · FY2014 · HD · contact PI
Integrative Cancer Genomics: Drivers, Pathways and Drugs$101,640
R01 · FY2014 · CA · contact PI
Integrative Cancer Genomics: Drivers, Pathways and Drugs$358,131
R01 · FY2013 · CA · contact PI
Integrative Cancer Genomics: Drivers, Pathways and Drugs$399,632
R01 · FY2012 · CA · contact PI
Genetic variation and regulatory networks: Mechanisms and complexity$89,960
DP2 · FY2009 · OD · contact PI
Genetic variation and regulatory networks: Mechanisms and complexity$2,415,000
DP2 · FY2007 · OD · contact PI